Shannon Hartman
Nurse Practitioner · Hagerstown, MDNPI 1528089323
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 305 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 305 payments — averaging $18.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$965
- Novo Nordisk$719
- Lilly USA, LLC$637
- AstraZeneca$611
- Pfizer$388
- GSK$313
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,50598%
- Education$1302%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 59 | $965 |
| Novo Nordisk | 39 | $719 |
| Lilly USA, LLC | 34 | $637 |
| AstraZeneca | 26 | $611 |
| Pfizer | 23 | $388 |
| GSK | 18 | $313 |
| Astellas Pharma US Inc | 9 | $251 |
| Abbott | 9 | $173 |
| Boehringer Ingelheim | 9 | $156 |
| Exact Sciences | 6 | $129 |
| Johnson & Johnson | 6 | $114 |
| Bayer | 6 | $112 |
| E.r. Squibb & Sons, L.L.C. | 6 | $100 |
| Otsuka America Pharmaceutical, Inc. | 6 | $93 |
| Phathom Pharmaceuticals, Inc. | 6 | $93 |
| Novartis | 5 | $79 |
| Nestle Healthcare Nutrition Inc. | 4 | $74 |
| Eisai Inc. | 3 | $67 |
| Amgen | 4 | $67 |
| Teva Pharmaceuticals USA, Inc. | 3 | $61 |
| Dexcom, Inc. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Boston Scientific | 2 | $47 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
| Vivus LLC | 2 | $30 |
| Biohaven Pharmaceuticals, Inc. | 2 | $29 |
| Biogen | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Seqirus USA Inc | 1 | $15 |
| Medtronic | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,635 in reported general payments places this provider in the 95th percentile of 1,562 nurse practitioner providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 15 | $28,924 |
| Rosuvastatin Calcium | 68 | $859 |
| Pregabalin | 20 | $777 |
| Tramadol Hcl | 89 | $555 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 13 | $512 |
| Metoprolol Succinate | 18 | $421 |
| Lorazepam | 41 | $342 |
| Amlodipine-OlmesartanAmlodipine Bes/Olmesartan Med | 12 | $342 |
| Alprazolam | 61 | $312 |
| Famotidine | 12 | $310 |
| Gabapentin | 23 | $285 |
| Buspirone Hcl | 19 | $274 |
| Fluticasone Propionate | 12 | $251 |
| Zolpidem Tartrate | 17 | $232 |
| Omeprazole | 19 | $209 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $637 | $28,92415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,562 nurse practitioner providers in Maryland.
Other nurse practitioner in Hagerstown
- Katey PurgasonHagerstown$6K
- Kate SmithHagerstown$6K
- Morgan GaleRockville$292K
- Sherilyn BrinkleyBaltimore$100K
- Michelle TurnerBaltimore$94K
- Nelli ZafmanLutherville$67K
- Ellen LancasterFallston$52K
- Doris TateEaston$34K
- Zeev NemirovskyBaltimore$19K
- Martha ReilleyAnnapolis$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.